Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Robyn J Barst
Affiliation
Columbia University
ORCID
Career Start Year
1981
Papers
226
H Index
89
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
26583838
Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension).
Int J Cardiol
2016
24566799
Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertension.
Eur Heart J
2015
26534956
Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.
Circulation
2015
26210752
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension.
J Heart Lung Transplant
2015
25837032
Validation of two predictive models for survival in pulmonary arterial hypertension.
Eur Respir J
2015
25320967
Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study.
Chest
2015
24176071
Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Am J Cardiol
2014
25697042
[Pediatric pulmonary hypertension].
Turk Kardiyol Dern Ars
2014
25697038
[New trial designs and potential therapies for pulmonary artery hypertension].
Turk Kardiyol Dern Ars
2014
25006452
Repair of congenital heart disease with associated pulmonary hypertension in children: what are the minimal investigative procedures? Consensus statement from the Congenital Heart Disease and Pediatric Task Forces, Pulmonary Vascular Research Institute (PVRI).
Pulm Circ
2014
24988120
Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.
PLoS One
2014
24815795
Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension.
J Heart Lung Transplant
2014
24637559
STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.
Circulation
2014
24628312
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.
Am J Respir Crit Care Med
2014
22661451
Demographics and outcomes of patients diagnosed with pulmonary hypertension with pulmonary capillary wedge pressures 16 to 18 mm Hg: insights from the REVEAL Registry.
Chest
2013
24618537
From short-term benefits to long-term outcomes: the evolution of clinical trials in pulmonary arterial hypertension.
Pulm Circ
2013
24355645
New trial designs and potential therapies for pulmonary artery hypertension.
J Am Coll Cardiol
2013
24355636
Pediatric pulmonary hypertension.
J Am Coll Cardiol
2013
24226806
Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association.
Circulation
2013
23953817
One-year experience with intravenous treprostinil for pulmonary arterial hypertension.
J Heart Lung Transplant
2013
23662203
Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee.
Pulm Circ
2013
23429998
Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
Chest
2013
23403476
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.
Circulation
2013
23502781
Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension.
Nat Genet
2013
23563261
Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice.
Eur Respir J
2013
22983573
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.
Haematologica
2013
21757572
Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Chest
2012
23009909
Congenital heart disease and pulmonary hypertension: pharmacology and feasibility of late surgery.
Prog Cardiovasc Dis
2012
22883740
Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY®.
Mayo Clin Proc
2012
22818063
Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study.
J Am Coll Cardiol
2012
22837854
Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension.
Pulm Circ
2012
22281797
An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.
Chest
2012
22240409
Clinical features of paediatric pulmonary hypertension: a registry study.
Lancet
2012
22086881
Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Circulation
2012
22128226
A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.
Circulation
2012
21778257
Portopulmonary hypertension: a report from the US-based REVEAL Registry.
Chest
2012
20558556
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.
Chest
2011
22034602
Classification of pediatric pulmonary hypertensive vascular disease: Does it need to be different from the adult classification?
Pulm Circ
2011
21926260
PET imaging may provide a novel biomarker and understanding of right ventricular dysfunction in patients with idiopathic pulmonary arterial hypertension.
Circ Cardiovasc Imaging
2011
21900080
Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.
Circulation
2011
21527519
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity.
Blood
2011
21546436
Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
Chest
2011
21357924
Pulmonary arterial hypertension: a comparison between children and adults.
Eur Respir J
2011
21256048
Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension.
J Heart Lung Transplant
2011
20010555
A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.
Clin Pharmacol Ther
2010
20688967
Pulmonary hypertension and NO in sickle cell.
Blood
2010
20801850
Children deserve the same rights we do: the need for paediatric pulmonary arterial hypertension clinical drug development.
Heart
2010
20939843
How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?
Int J Clin Pract Suppl
2010
21029834
Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings.
Am J Cardiol
2010
20522584
Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective.
Chest
2010
1 - 50 of 226
Column Actions
Search
Recommended Authors
Meghan M Cirulis
Intermountain Medical Center
Career Start Year
2016
Number of shared co-authors
0
Alexandra Arvanitaki
AHEPA University Hospital, Aristotle University of Thessaloniki
Career Start Year
2016
Number of shared co-authors
1
Jessica Badlam
University of Vermont
Career Start Year
2014
Number of shared co-authors
5
Aleksander Kempny
Royal Brompton Hospital
Career Start Year
2010
Number of shared co-authors
2
Jesse J Esch
Boston Children's Hospital, Harvard Medical School
Career Start Year
2008
Number of shared co-authors
5
Emilia M Swietlik
University of Cambridge, Heart and Lung Research Institute
Career Start Year
2006
Number of shared co-authors
3
Ali N Zaidi
Kravis Children's Hospital
Career Start Year
2005
Number of shared co-authors
4
Gerhard-Paul Diller
University Hospital Muenster
Career Start Year
2004
Number of shared co-authors
2
Alexander R Opotowsky
Heart Institute, Cincinnati Children's Hospital Medical Center
Career Start Year
2003
Number of shared co-authors
13
Michael G Risbano
University of Pittsburgh
Career Start Year
2002
Number of shared co-authors
3
Stephen Y Chan
and Blood Vascular Medicine Institute, University of Pittsburgh School of Medicine
Career Start Year
1999
Number of shared co-authors
6
Curt J Daniels
The Ohio State University Wexner Medical Center
Career Start Year
1997
Number of shared co-authors
11
Seema Mital
Hospital for Sick Children
Career Start Year
1997
Number of shared co-authors
10
Russel Hirsch
Cincinnati Children's Hospital Medical Center
Career Start Year
1996
Number of shared co-authors
10
Wendy M Book
Emory University Division of Cardiology Atlanta Georgia USA.
Career Start Year
1996
Number of shared co-authors
3
Julie A Vincent
Columbia University Medical Center
Career Start Year
1993
Number of shared co-authors
10
Michael A Gatzoulis
National Heart & Lung Institute, Imperial College London.
Career Start Year
1992
Number of shared co-authors
6
Michael A Solomon
Clinical Center/Critical Care Medicine Department, National Institutes of Health
Career Start Year
1992
Number of shared co-authors
2
Daniel J Penny
Baylor College of Medicine and Texas Children's Hospital.
Career Start Year
1991
Number of shared co-authors
5
Angela M Sharkey
Wake Forest University School of Medicine
Career Start Year
1989
Number of shared co-authors
1
Sergio V Perrone
El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute
Career Start Year
1988
Number of shared co-authors
0
Jonathan J Rome
The Children's Hospital of Philadelphia
Career Start Year
1988
Number of shared co-authors
12
Jane A Leopold
Brigham and Women's Hospital and Harvard Medical School
Career Start Year
1986
Number of shared co-authors
7
Boyd Taylor Thompson
Massachusetts General Hospital, Harvard School of Medicine,
Career Start Year
1986
Number of shared co-authors
0
Jonathan T Bricker
Carver College of Medicine, The University of Iowa
Career Start Year
1984
Number of shared co-authors
7
Andrew N Redington
The Heart Institute, Cincinnati Children's Hospital Medical Center
Career Start Year
1984
Number of shared co-authors
5
Francis X McGowan
Children's Hospital of Philadelphia
Career Start Year
1983
Number of shared co-authors
5
Lynn Mahony
University of Texas Southwestern Medical Center
Career Start Year
1981
Number of shared co-authors
4
Lee N Benson
the Hospital for Sick Children
Career Start Year
1979
Number of shared co-authors
8
Douglas Moodie
Texas Children's Hospital, Baylor College of Medicine
Career Start Year
1972
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Dunbar Ivy
Heart Institute, Children's Hospital Colorado, University of Colorado
Co-authored papers
19
James A Knowles
Co-authored papers
12
Mark T Gladwin
University of Maryland School of Medicine
Co-authored papers
9
Steven H Abman
Children's Hospital Colorado
Co-authored papers
8
Victor R Gordeuk
Co-authored papers
6
Wendy K Chung
Boston Children's Hospital, Harvard Medical School
Co-authored papers
4
Erik Magnus Ohman
Duke University Medical Center-Duke Clinical Research Institute
Co-authored papers
3
Frans Van de Werf
Co-authored papers
3
Anne Keogh
Co-authored papers
3
Jane E Freedman
Vanderbilt University Medical Center
Co-authored papers
3
David L Wessel
Children's National Hospital, George Washington University School of Medicine
Co-authored papers
3
Catherine L Webb
University of Michigan ann arbor
Co-authored papers
3
Christopher P Cannon
Brigham and Women's Hospital
Co-authored papers
3
Mehdi Nouraie
Co-authored papers
3
Kenneth I Ataga
Center for Sickle Cell Disease, University of Tennessee Health Science Center
Co-authored papers
2
Jeffrey A Feinstein
Stanford University School of Medicine
Co-authored papers
2
Norman Stockbridge
Center for Drug Evaluation and Research
Co-authored papers
2
Garry R Cutting
Johns Hopkins University School of Medicine
Co-authored papers
2
Francis Sessions Cole
Washington University in St. Louis School of Medicine
Co-authored papers
2
James E Gern
University of Wisconsin School of Medicine and Public Health
Co-authored papers
2
John Wright
Co-authored papers
2
Richard Ringel
John Hopkins School of Medicine
Co-authored papers
2
Kirk C Wilhelmsen
West Virginia University
Co-authored papers
2
James G Taylor
Center for Sickle Cell Disease, Howard University College of Medicine
Co-authored papers
2
Michael J Landzberg
Harvard Medical School
Co-authored papers
2
Dianne L Atkins
University of Iowa
Co-authored papers
2
Gabriel G Haddad
university of california san diego
Co-authored papers
2
Hugh D Allen
Baylor College of Medicine
Co-authored papers
1
John A Phillips
Vanderbilt University Medical Center
Co-authored papers
1
Carole A Warnes
Mayo Clinic Rochester MN USA.
Co-authored papers
1
1 - 30